Related Experiment Video
Updated: Aug 17, 2026

Analysis of Cell Cycle Position in Mammalian Cells
Published on: January 21, 2012
Regulation of p21WAF1/CIP1 expression by p53-independent pathways
1Howard Hughes Medical Institute, Department of Medicine, Genetics, and Cancer Center, Philadelphia, Pennsylvania 19104, USA.
Abstract:
The CDK-inhibitor p21WAF1/CIP1 has been implicated as a growth arrest mediator in p53-tumour suppression, cellular senescence and terminal differentiation. Cell type specific differences in p53-independent p21 expression and cell cycle arrest were found following treatment of human tumour cell lines with serum, 12-O-tetradecanoyl-phorbol-13-acetate (TPA), or okadaic acid (OA). TPA induced p21 in ML1, K562 and HL60 leukemia cells, whereas OA induced p21 in SW480 and GM4723 carcinoma cells as well as in leukemic cells. In addition, TPA- and serum- but not OA-induced cell cycle arrest was reversed upon return of p21 to basal levels. To further investigate the mechanisms underlying p53-independent regulation of p21, the transcription inhibitor, Actinomycin D (AMD), was used to block p21 expression. The results showed a complete inhibition of p21 mRNA and protein induction by TPA or adriamycin but little effect on p21 mRNA induced by OA in the presence of AMD. These results suggested that TPA-induced p21 expression requires transcription initiation, while a post-transcriptional mechanism may be involved in OA-induction as well. Transient transfection assays with p21 promoter-luciferase reporters and TPA or OA treatment further confirmed that TPA, and to a lesser extent, OA, initiated transcription of p21. Finally, the protein kinase C inhibitor, staurosporine, was found to interfere with p21 induction and prevent cell cycle arrest following treatment with TPA but not OA, suggesting a requirement for PKC in TPA activation of p21 expression.
Insights
The cyclin-dependent kinase inhibitor p21 (also known as p21WAF1/CIP1) mediates cell growth arrest. Its induction varies by cell type and stimulus, with distinct mechanisms for TPA and okadaic acid (OA) pathways.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- The cyclin-dependent kinase inhibitor p21WAF1/CIP1 is a key mediator of p53-dependent tumor suppression, cellular senescence, and terminal differentiation.
- p53-independent regulation of p21 expression and cell cycle arrest is crucial for understanding its diverse roles in cancer.
Purpose of the Study:
- To investigate the cell type-specific differences in p53-independent p21 expression and cell cycle arrest.
- To elucidate the distinct molecular mechanisms regulating p21 induction by different stimuli, such as 12-O-tetradecanoyl-phorbol-13-acetate (TPA) and okadaic acid (OA).
Main Methods:
- Treatment of human tumor cell lines with serum, TPA, or OA.
- Use of Actinomycin D (AMD) to inhibit transcription and assess p21 mRNA and protein induction.
- Transient transfection assays with p21 promoter-luciferase reporters.
- Inhibition of protein kinase C (PKC) with staurosporine.
Main Results:
- TPA induced p21 in leukemia cells, while OA induced p21 in carcinoma and leukemia cells.
- TPA-induced p21 expression requires transcription initiation, whereas OA-induction may involve post-transcriptional mechanisms.
- PKC is required for TPA-induced p21 expression and cell cycle arrest, but not for OA-induced effects.
Conclusions:
- p53-independent p21 regulation exhibits cell type specificity and stimulus-dependent mechanistic differences.
- TPA and OA activate p21 expression through distinct pathways, involving transcriptional initiation and potentially post-transcriptional regulation, respectively.
- PKC plays a critical role in TPA-mediated p21 induction and cell cycle arrest.
Related Concept Videos
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
Inhibition of Cdk Activity
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
DNA Damage Can Stall the Cell Cycle

